Who Paid My Doc
Neha Naik-Desai
Geriatric Medicine Salem, OR Medical Doctor
NPI 1326450651 CMS profile 5692360
5050 Skyline Village Loop S, Suite 110, Salem, OR 97306
General payments
$21
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Neha Naik-Desai of Salem, OR is reported in the CMS Open Payments database as having received $21 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 10th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $21 | 1 |
Beside peers
- Neha Naik-Desai
- Geriatric Medicine median
- Middle half of Geriatric Medicine
- National median
In program year 2025, general payments to Neha Naik-Desai were reported at $0. Among 1,028 Geriatric Medicine profiles paid that year, the median was $123 and the middle half received between $35 and $408.
Show as a table
| Year | Neha Naik-Desai | Geriatric Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $21 | $122 | $40–$435 | $163 |
| 2020 | $0 | $98 | $25–$349 | $114 |
| 2021 | $0 | $125 | $34–$441 | $132 |
| 2022 | $0 | $124 | $36–$408 | $149 |
| 2023 | $0 | $121 | $41–$383 | $160 |
| 2024 | $0 | $134 | $41–$435 | $164 |
| 2025 | $0 | $123 | $35–$408 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 137 drugsPart D claims
8,375
Drug cost
$702,299
Branded share of claims
19.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 106 | $133,890 | |
| Eliquis Apixaban | Brand | 100 | $103,310 | |
| Trulicity Dulaglutide | Brand | 65 | $98,452 | |
| Jardiance Empagliflozin | Brand | 63 | $84,057 | |
| Mounjaro Tirzepatide | Brand | 33 | $46,835 | |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 27 | $24,334 | |
| Januvia Sitagliptin Phosphate | Brand | 23 | $19,321 | |
| Myrbetriq Mirabegron | Brand | 12 | $15,363 | |
| Tresiba Flextouch U-100 Insulin Degludec | Brand | 18 | $14,921 | |
| Farxiga Dapagliflozin Propanediol | Brand | 13 | $13,836 |
The 10 drugs with the highest cost, of 137 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 36 billing codesPaid by Medicare
$87,615
Medicare patients
244
Services billed
1,159
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 67% | |
| Arthritis | 32% | |
| Diabetes | 22% | |
| Chronic kidney disease | 20% | |
| Depression | 20% | |
| Ischemic heart disease | 18% | |
| Osteoporosis | 18% | |
| Atrial fibrillation | 13% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Pcv20 vaccine im 90677 | Office | 57 | 57 | $16,566 |
| Vaccine for influenza for injection into muscle 90662 | Office | 16 | 17 | $1,063 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Geriatric Medicine in Oregon
Nu Nwe Tun
Geriatric Medicine · Hermiston, OR
Jitendra Patel
Geriatric Medicine · Brookings, OR
Ranganathan Rajendran
Geriatric Medicine · Roseburg, OR
John Williams
Geriatric Medicine · McMinnville, OR
Maria Angela Galang
Geriatric Medicine · McMinnville, OR
John Roberts
Geriatric Medicine · Eugene, OR
Related records
Geriatric Medicine in Oregon
Practitioners in the same specialty and state, ranked by reported value.
All Geriatric Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Oregon
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.